Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biodistribution and Safety of the PET Probes [18F]FPRGD2 and [18F]FPPRGD2

NCT01383135 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT01383135
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01383135 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biodistribution and Safety of the PET Probes [18F]FPRGD2 and [18F]FPPRGD2
Lead sponsor
Stanford University
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2010
Completion date
December 31, 2013
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, glioblastoma, non-small-cell lung cancer, other cancers